The authors explored the combination between zeste homolog 2 (EZH2) inhibitor and an agonist antibody targeting the T cell costimulatory receptor 4-1BB.
[Frontiers in Immunology]
Sorry, but the selected Zotpress account can't be found.
Sorry, but the selected Zotpress account can't be found.